An antiinflammatory immunogen from yeast culture induces activation and alters chemokine receptor expression on human natural killer cells and B lymphocytes in vitro

Nutrition Research

Volumn 27, Issue 6, 2007, Pages 327-335

  Jensen, Gitte S ^a   Hart, Aaron N ^a   Schauss, Alexander G ^b  

^a NIS Labs   (United States)

^b AIBMR Life Sciences Inc   (United States)

Author keywords

Antiinflammatory; B cell; Chemokine receptor; Human; Immune; Interferon; NK cell; ROS; Saccharomyces cerevisiae

Indexed keywords

B7 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR4; EPICOR; FUCOIDIN; FUNGUS ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; PHYTOHEMAGGLUTININ; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BYSTANDER EFFECT; CHEMOTAXIS; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NEUTROPHIL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; YEAST;

SACCHAROMYCES CEREVISIAE;

EID: 34250705805     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.04.008     Document Type: Article

References (32)

1. Schauss A.G. Suplemento alimentar unico que proporciona a melhoria imunologica. A novel yeast fermentate. Rev Bioquimica Med 15 3 (2006) 30-32
2. Schauss A.G., and Vojdani A. A discovery of an edible fermentation product with unusual immune enhancing properties in humans. FASEB J 20 (2006) A143
3. Plat J., and Mensink R.P. Food components and immune function. Curr Opin Lipidol 16 (2005) 31-37
4. Kournikakis B., Mandeville R., Brousseau P., and Ostroff G. Anthrax-protective effects of yeast beta 1,3 glucans. Med Gen Med 5 (2003) 1
5. Hong F., Hansen R.D., Yan J., Allendorf D.J., Baran J.T., Ostroff G.R., et al. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res 63 (2003) 9023-9031
6. Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., et al. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173 (2004) 797-806
7. Pelizon A.C., Kaneno R., Soares A.M., Meira D.A., and Sartori A. Down-modulation of lymphoproliferation and interferon-gamma production by beta-glucan derived from Saccharomyces cerevisiae. Mem Inst Oswaldo Cruz 98 (2003) 1083-1087
8. Davis M.E., Maxwell C.V., Erf G.F., Brown D.C., and Wistuba T.J. Dietary supplementation with phosphorylated mannans improves growth response and modulates immune function of weanling pigs. J Anim Sci 82 (2004) 1882-1891
9. Cassone A., Marconi P., and Bistoni F. Cell wall of Candida albicans and host response. Crit Rev Microbiol 15 (1987) 87-95
10. Roeder A., Kirschning C.J., Rupec R.A., Schaller M., Weindl G., and Korting H.C. Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 42 (2004) 485-498
11. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21 Suppl 97 (1968) 77
12. English D., and Andersen B.R. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradient of Ficoll-Hypaque. J Immunol Methods 5 (1974) 249
13. Schauss A.G., Wu X., Prior R.L., Ou B., Huang D., Owens J., et al. Antioxidant capacity and other bioactivities of the freeze-dried Amazonian palm berry, Euterpe oleraceae mart. (acai). J Agric Food Chem 54 22 (2006) 8604-8610
14. Peters C.E., Woodside S.M., and Eaves A.C. Isolation of subsets of immune cells. Methods Mol Biol 302 (2005) 95-116
15. Horan P.K., and Slezak S.E. Stable cell membrane labelling. Nature 340 6229 (1989) 167-168
16. Ding Z., Issekutz T.B., Downey G.P., and Waddell T.K. l-Selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration. Blood 101 11 (2003) 4245-4252
17. Ludbrook J. Issues in biomedical statistics: comparing means under normal distribution theory. Aust N Z J Surg 65 4 (1995) 267-272
18. Livingston E.H. Who was Student and why do we care so much about his t-test?. J Surg Res 118 1 (2004) 58-65
19. Kontogianni M.D., Zampelas A., and Tsigos C. Nutrition and inflammatory load. Ann N Y Acad Sci 1083 (2006) 214-238
20. Hu F.B., and Willett W.C. Optimal diets for prevention of coronary heart disease. JAMA 288 20 (2002) 2569-2578
21. Fujioka K. Metabolic syndrome treatment strategies. Pharmacotherapy 26 12 Pt 2 (2006) 222S-226S
22. Kao P.C., Shiesh S.C., and Wu T.J. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci 36 2 (2006) 163-169
23. Trosko J.E. Dietary modulation of the multistage, multimechanisms of human carcinogenesis: effects on initiated stem cells and cell-cell communication. Nutr Cancer 54 1 (2006) 102-110
24. Schottenfeld D., and Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56 2 (2006) 69-83
25. Tapsell L.C., Hemphill I., Cobiac L., Patch C.S., Sullivan D.R., Fenech M., et al. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185 4 Suppl (2006) S4-S24
26. Philpott M., and Ferguson L.R. Immunonutrition and cancer. Mutat Res 551 1-2 (2004) 29-42
27. Barbaro G., Scozzafava A., Mastrolorenzo A., and Supuran C.T. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. Curr Pharm Design 11 (2005) 1805-1843
28. Li J.H., and Zhang J. PARP inhibitors. IDrugs 4 (2001) 804-812
29. Santoro F., Vassena L., and Lusso P. Chemokine receptors as new molecular targets for antiviral therapy. New Microbiol 27 (2004) 17-29
30. Stenstad H., Ericsson A., Johansson-Lindbom B., Svensson M., Marsal J., Mack M., et al. Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. Blood 107 (2006) 3447-3454
31. Pabst O., Ohl L., Wendland M., Wurbel M.A., Kremmer E., Malissen B., et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J Exp Med 199 (2004) 411-416
32. Eksteen B., Grant A.J., Miles A., Curbishley S.M., Lalor P.F., Hubscher S.G., et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 200 (2004) 1511-1517